BMBL three-lens brief
Evidence-based stock research on BMBL. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Analyst mean target $3.79 — 27% above current (10 analysts). · Trading at 9% of its 52-week range — deep in the lower band.
- Trading at 9% of its 52-week range — deep in the lower band.
- Currently unprofitable on a trailing basis — no P/E multiple available.
- Analyst mean target $3.79 — 27% above current (10 analysts).
BMBL closed at $2.98 (+1.71%) as of 2026-09-11. Market cap: $456.59M. Price is above the 50-day MA and below the 200-day MA. Positives: analyst mean target $3.79 — 27% above current (10 analysts).. Concerns: trading at 9% of its 52-week range — deep in the lower band.; currently unprofitable on a trailing basis — no P/E multiple available.. Last quarter: Revenue $210.53M, net income -$110.06M, free cash flow $193.59M.
Why three lenses on BMBL, not one.
A single reasoning model has blind spots it doesn’t know about. We examine BMBLacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/BMBL" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath BMBL brief"></iframe>